RT Journal Article
T1 Epigenetic changes in the metabolically healthy obese: A case-control versus a prospective study.
A1 Linares-Pineda, Teresa Maria
A1 Boughanem, Hatim
A1 Gutierrez-Repiso, Carolina
A1 Macias-Gonzalez, Manuel
A1 Andres-Leon, Eduardo
A1 Rojo-Martinez, Gemma
A1 Valdes, Sergio
A1 Tinahones, Francisco J
A1 Morcillo, Sonsoles
K1 Insulin Resistance
K1 Obesity, Metabolically Benign
K1 Diabetes Mellitus, Type 2
K1 Cardiovascular Diseases
K1 Global Health
AB Obesity has become a worldwide health problem, in which latest statistics reported an increased trend over the last years. Accordingly, long- term obesity is involved in an increased risk of developing several metabolic diseases, such as cardiovascular diseases, insulin resistance or type 2 diabetes. Although it is common to find obesity- related disorders in the majority of individuals with obesity, some of them do not show metabolic complications.1 Obese people without these metabolic disorders are defined as metabolically healthy obesity (MHO) individuals, whereas those who present metabolic complications are known as metabolically unhealthy obesity (MUO) subjects.
PB John Wiley & Sons
YR 2022
FD 2022-07-12
LK http://hdl.handle.net/10668/19947
UL http://hdl.handle.net/10668/19947
LA en
NO Linares-Pineda TM, Boughanem H, Gutiérrez-Repiso C, Macías-González M, Andrés-León E, Rojo-Martínez G, et al. Epigenetic changes in the metabolically healthy obese: A case-control versus a prospective study. Eur J Clin Invest. 2022 Aug;52(8):e13783
DS RISalud
RD Jun 1, 2025